Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
PCDH11Y
REST API REST API
Homo sapiens
PCDH11Y is differentially expressed in 109 experiments: 80 organism parts: amygdala, brain, ... (78 more);, 56 disease states: normal, Huntington's disease, ... (54 more);, 27 cell types 73 cell lines 12 compound treatments and 49 other conditions.
Synonyms PCDHY, PCDH22
Orthologs PCDH11Y (Danio rerio)   Pcdh11x (Mus musculus)   ENSGALG00000006851 (Gallus gallus)   ENSBTAG00000001911 (Bos taurus)   Pcdh11x (Rattus norvegicus)   pcdh11x (Xenopus laevis)   ENSCING00000009603 (Ciona intestinalis)   ENSCING00000002953 (Ciona intestinalis)   ENSCING00000006850 (Ciona intestinalis)   ENSCING00000005572 (Ciona intestinalis)   ENSCAFG00000017457 (Canis familiaris)   (Compare orthologs)
Gene Ontology Term membrane, homophilic cell adhesion, calcium ion binding
InterPro Term Cadherin, Cadherin_N, Protocadherin
UniProt Accession Q70LR5, Q70LR4, Q9BZA8
Search EB-eye ENSG00000099715
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-15765, E-AFMX-5, E-MEXP-1251, E-MTAB-24, E-MTAB-25, ... (17 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-1880, E-GEOD-1309, E-GEOD-19639, E-GEOD-22639, ... (13 experiments)

Factor Value U/D Experiments
Hep-2
1
E-MTAB-62
A459
1
E-GEOD-17347
Capan1
1
E-MTAB-37
NCIH1703
1
E-MTAB-37
SJSA1
1
E-MTAB-37
NA19119
1
E-GEOD-19480
67 more value(s).


Cell type

studied in E-GEOD-10797, E-AFMX-5, E-GEOD-18811, E-MTAB-25, E-GEOD-21668, ... (18 experiments)

Factor Value U/D Experiments
epithelial cell
1
E-GEOD-10797
lung carcinoma
1
E-GEOD-17347
leydig cell
1
E-MTAB-25
iPSC derived from hASC using minicircle reprogramming vector
1
E-GEOD-20033
mesenchymal stem cell
1
E-MEXP-466
primary fibroblast
1
E-MEXP-66
21 more value(s).


Disease state

studied in E-GEOD-5390, E-GEOD-3307, E-MEXP-1922, E-GEOD-1880, E-GEOD-2466, ... (21 experiments)

Factor Value U/D Experiments
undifferentiated sarcoma
1
E-MEXP-1922
neuromuscular pain
1
E-GEOD-7307
extranodal NK/T-cell lymphoma
1
E-TABM-702
Down syndrome
1
E-GEOD-5390
malignant peripheral nerve sheath tumor
1
E-MTAB-62
neuroblastoma
1
E-MTAB-62
50 more value(s).


Compound treatment

studied in E-MEXP-1269, E-GEOD-3284, E-GEOD-412, E-GEOD-2292, E-GEOD-7307, ... (7 experiments)

Factor Value U/D Experiments
not specified
1
E-GEOD-20081
Cxcl12
1
E-GEOD-7307
5-aza-2'-deoxycytidine + trichostatin A
1
1
E-MEXP-1269
bacterial endotoxin
1
E-GEOD-3284
none
1
E-GEOD-412
17beta-estradiol
4
1
E-GEOD-2292
6 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
thapsigargin
1
E-GEOD-19519


Biopsy tissue
studied in E-GEOD-5851

BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Blood/non-blood meta-groups
studied in E-MTAB-62

Bmngrd
studied in E-GEOD-20194, E-GEOD-16716

Cancer site
studied in E-GEOD-4271

Classifier
studied in E-GEOD-3493

Clinical history
studied in E-GEOD-19743, E-GEOD-16363

Clinical info
studied in E-MTAB-37, E-GEOD-19348, E-MEXP-1251, E-GEOD-1563

Clinical treatment
studied in E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-MEXP-2359, E-MTAB-62

Disease staging
studied in E-GEOD-19743, E-GEOD-1561, E-TABM-147, E-GEOD-21138

Environmental stress
studied in E-GEOD-1643

Epiregulin elisa conc ng ml
studied in E-GEOD-5851

Er
studied in E-GEOD-20194, E-GEOD-16716

Estrogen receptor status
studied in E-GEOD-6532

Ethnic group
studied in E-GEOD-20194, E-GEOD-16716

family id
studied in E-GEOD-19519

Genetic modification
studied in E-MEXP-1482, E-MEXP-563

Genotype
studied in E-GEOD-2466, E-TABM-321, E-GEOD-17347

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-MEXP-1446

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Her2 ihc
studied in E-GEOD-20194, E-GEOD-16716

Individual
studied in E-MTAB-197, E-GEOD-974, E-GEOD-1432, E-MEXP-2069, E-GEOD-1926, ... (20 experiments)

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Metastasis
studied in E-GEOD-18105

organ
studied in E-GEOD-24283

Organism status
studied in E-GEOD-19188

Phenotype
studied in E-GEOD-1309, E-GEOD-1657, E-GEOD-7114

Population
studied in E-GEOD-4922

Progesterone receptor status
studied in E-GEOD-6532

Protocol type
studied in E-GEOD-3254, E-GEOD-19445

Replicate
studied in E-GEOD-10797

RNAi
studied in E-GEOD-12438, E-GEOD-3485

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743

Sex
studied in E-GEOD-2466

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-19188

Tbefore
studied in E-GEOD-20194, E-GEOD-16716

Treatment
studied in E-GEOD-19246

Treatment code
studied in E-GEOD-20194, E-GEOD-16716

Treatments comments
studied in E-GEOD-20194, E-GEOD-16716

Processing time: 0.605 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM